California Nanotechnologies Corp (CNO) — Capital Reinvestment Ratio

Latest as of May 2025: 0.46x

California Nanotechnologies Corp (CNO) has a Capital Reinvestment Ratio of 0.46x as of May 2025, meaning it reinvests 0% of its operating cash flow (CA$71.59K) in capital expenditures (CA$32.84K). See California Nanotechnologies Corp balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.46x
Capex / Operating Cash Flow

Operating Cash Flow

CA$71.59K
CAD

Capital Expenditures

CA$32.84K
CAD

Data as of

May 2025
Most recent filing

California Nanotechnologies Corp Capital Reinvestment Ratio (2018–2025)

This chart tracks California Nanotechnologies Corp's Capital Reinvestment Ratio across 8 annual periods. Check CNO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for California Nanotechnologies Corp (2018–2025)

Year-by-year Capital Reinvestment Ratio for California Nanotechnologies Corp from 2018 to 2025. For live market cap and broader valuation context, see California Nanotechnologies Corp stock valuation.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2025 0.73x CA$2.92 Million CA$2.13 Million ▲ +430.4%
2024 0.14x CA$104.28K CA$14.30K ▼ -12.8%
2023 0.16x CA$717.01K CA$112.75K ▼ -10.7%
2022 0.18x CA$54.97K CA$9.68K ▼ -24.3%
2021 0.23x CA$33.20K CA$7.72K ▲ +444.0%
2020 0.04x CA$180.62K CA$7.72K ▼ -80.5%
2019 0.22x CA$122.23K CA$26.78K ▼ -98.8%
2018 17.71x CA$47.31K CA$837.71K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow